Education
About Us
Working with TipRanks
Follow Us
Tempus AI, Inc. Class A (TEM)
NASDAQ:TEM
Earnings Data
Report Date
Aug 12, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
―Last Year’s EPS
-0.63Same Quarter Last Year
Moderate Buy
Based on 9 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 24, 2025
|% Change Since: -26.19%
|Next Earnings Date:Aug 12, 2025
Earnings Call Sentiment|Positive
The earnings call reflected a strong performance in revenue and gross profit growth, successful strategic acquisitions, and positive future guidance. Despite some minor challenges with data delivery timing and adjusted growth expectations for Ambry Genetics, the overall outlook remains positive with significant achievements in AI diagnostics reimbursement and strategic partnerships.Company Guidance
During the call, Tempus provided guidance for 2025, highlighting an increase in revenue projections from $1.23 billion to $1.24 billion. The company expects to generate approximately $5 million in adjusted EBITDA, indicating a positive shift towards profitability. Key metrics from the fourth quarter of 2024 include a 35.8% year-over-year revenue growth and a 49.7% increase in gross profit. Tempus also reported a total remaining contract value of $940 million and a net revenue retention rate of 140%. The acquisition of Ambry Genetics was completed on February 3, 2025, and is expected to contribute to revenue in the first quarter. Furthermore, Tempus extended its agreement with Google for another five years, securing favorable rates. Overall, Tempus remains focused on sustaining growth and leveraging its two main businesses, Genomics and Data, while also integrating strategic acquisitions.Accelerated Revenue and Gross Profit Growth
Tempus reported a 35.8% year-over-year revenue increase in Q4 2024, with gross profit growth of 49.7%.
Strong Contract Value and Retention
The year ended with $940 million in total remaining contract value and 140% net revenue retention.
Acquisition of Ambry Genetics
Tempus completed the acquisition of Ambry Genetics on February 3, 2025, which is expected to contribute positively to their financials.
Increased Revenue Guidance for 2025
Revenue guidance was increased from $1.23 billion to $1.24 billion for 2025, with an expectation to be adjusted EBITDA positive at around $5 million.
Extended Agreement with Google
Tempus extended its agreement with Google for another five years, securing favorable rates.
AI Diagnostics Reimbursement Milestone
Tempus's AI diagnostics received reimbursement, indicating a positive shift for AI-based diagnostics.
---
TEM Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
TEM Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 24, 2025 | $69.57 | $59.10 | -15.05% |
| Nov 04, 2024 | $49.50 | $44.50 | -10.10% |
| Aug 06, 2024 | $40.65 | $38.82 | -4.50% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Tempus AI, Inc. Class A (TEM) report earnings?
Tempus AI, Inc. Class A (TEM) is schdueled to report earning on Aug 12, 2025, TBA Not Confirmed.
What is Tempus AI, Inc. Class A (TEM) earnings time?
Tempus AI, Inc. Class A (TEM) earnings time is at Aug 12, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TEM EPS forecast?
Currently, no data Available
---
